- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus, Type 2 in Germany
Total 1233 results
-
GlaxoSmithKlinePPDCompletedDiabetes Mellitus, Type 2Spain, Germany, Hungary, Italy, Philippines, France, United States, Mexico, Brazil, South Africa, Korea, Republic of, Canada, Poland, United Kingdom
-
Novo Nordisk A/SRecruiting
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2Korea, Republic of, United States, Germany
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
TakedaCompletedType 2 DiabetesUnited States, Poland, United Kingdom, Germany, South Africa, Finland, Estonia, Slovakia, Czech Republic
-
Hoffmann-La RocheCompletedCardiovascular Disease, Diabetes Mellitus Type 2Germany, Spain, Korea, Republic of, United States, Colombia, Mexico, Hungary, Canada, Austria, Estonia, Malaysia, Australia, Poland, Thailand, Czech Republic, Latvia, Italy, Romania, Russian Federation, Chile, Lithuania, Sweden, United... and more
-
IKFE Institute for Clinical Research and DevelopmentTakeda; Heidelberg University; Johannes Gutenberg University MainzCompletedCardiovascular Disease | Type 2 Diabetes MellitusGermany
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Japan, Canada, United Kingdom, Denmark, United States
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Poland, Ukraine, United Kingdom, Mexico, Spain, Romania, Israel, Canada, New Zealand, Singapore, Russian Federation, Chile, Puerto Rico, Thailand, Hungary, Austria, Lithuania, Malaysia, Philippines, Australia, India, South... and more
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Bulgaria, Canada, Denmark, Germany, Norway, Peru, Poland, South Africa, Spain, Sweden, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Bulgaria, Russian Federation, United Kingdom, Hungary, Romania, Finland, Canada, Austria, Germany, Netherlands, Slovakia, Spain
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2Germany, France, Spain
-
University Hospital TuebingenActive, not recruitingDiabetes Mellitus, Type 2 | Insulin Resistance | OsteoporosisGermany
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Austria, Canada, Italy, Netherlands, Spain, United Kingdom, Taiwan, Thailand, Bulgaria, Belgium, Germany, Korea, Republic of, Hungary, Philippines, China, Malaysia, Hong Kong, New Zealand, Argentina, Czechia, Slovakia, Braz... and more
-
University Hospital TuebingenCompletedObesity | Diabetes Mellitus, Type 2Germany
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
SanofiCompletedType 2 Diabetes MellitusBrazil, Peru, United States, Australia, Canada, Chile, Germany, Guatemala, Mexico, Poland, Romania, Russian Federation, Ukraine
-
GlaxoSmithKlineDuke Clinical Research InstituteCompletedDiabetes MellitusUnited States, Argentina, Germany, Poland, Russian Federation, Spain, Taiwan, Czechia, Hungary, Italy, Ukraine, Belgium, Netherlands, South Africa, Sweden, Thailand, Korea, Republic of, Mexico, Bulgaria, Hong Kong, Peru, Philippines, Gree... and more
-
Universitätsklinikum Hamburg-EppendorfAstraZenecaTerminatedObesity | Diabetes Mellitus, Type 2Germany
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, United Kingdom, Germany, Mexico, Romania, Argentina, Canada, Puerto Rico, Israel, Italy, Slovakia
-
Eli Lilly and CompanyCompletedDiabetes | Type 2 DiabetesUnited States, China, Germany, Mexico, Brazil, Canada, Japan, Korea, Republic of, Puerto Rico, Czechia, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Spain, China, India, Russian Federation, Turkey, Germany, Japan, United Kingdom, France, United States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Russian Federation, United Kingdom, Vietnam, Germany, Hungary, Finland, Norway, Netherlands, Slovakia, India
-
AstraZenecaTerminatedType 2 DiabetesItaly, United Kingdom, Germany, Philippines, Malaysia, Sweden, Finland, Canada, India, Australia, Singapore
-
ChemoCentryxCompletedType 2 Diabetes Mellitus | Diabetic NephropathyPoland, United Kingdom, Germany, Belgium, Hungary, Czechia
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Germany, Argentina, Brazil, Turkey, Hungary, Italy, Russian Federation, Slovakia, Belgium, Czechia, Greece, Mexico, Romania
-
Mira ZuidgeestSanofi; Innovative Medicines Initiative; IMI Trials@Home consortiumRecruitingDiabetes Mellitus, Type 2United Kingdom, Denmark, Germany
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Argentina, Germany, United States
-
Boehringer IngelheimCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, United States, Estonia, Mexico, South Africa, Taiwan, Russian Federation, Canada, Slovakia, United Kingdom, Malaysia, Thailand, Australia, Hungary, Bulgaria, Brazil, Germany, Lithuania, Denmark, Romania, Ukraine, Poland, India, Israe... and more
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Spain, Italy, United States, Germany, United Kingdom, Russian Federation, Canada, Poland, Puerto Rico, Macedonia, The Former Yugoslav Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael, Spain, China, Turkey, Germany, Poland, Italy, Canada, Portugal
-
MetaCure (USA), Inc.TerminatedDiabetes Mellitus, Type 2Germany, Czech Republic, Romania
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Colombia, Russian Federation, Germany, Hungary, Italy, Mexico, Peru, Romania, Slovakia, Brazil, El Salvador
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
MedImmune LLCCompletedRenal Insufficiency | Type II Diabetes MellitusUnited Kingdom, Germany
-
Hoffmann-La RocheRoche Diabetes Care Deutschland GmbHCompleted
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
-
AfimmuneTerminatedType 2 Diabetes | HypertriglyceridemiaGeorgia, United States, Germany, Israel, Latvia, Switzerland
-
TakedaCompleted
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2Germany
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Germany
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Aarhus University HospitalUniversity of Southern DenmarkCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic Polyneuropathy | Hereditary Axonal Neuropathy | Hereditary Demyelinated Neuropathy | Polyneuropathy, Inflammatory Demyelinating, ChronicDenmark, Germany